Hanlon Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$530K Sell
576
-15
-3% -$15.2K 0.29% 119
2025
Q4
$635K Buy
591
+115
+24% +$110K 0.35% 99
2025
Q3
$363K Buy
476
+86
+22% +$64K 0.22% 148
2025
Q2
$304K Buy
390
+72
+23% +$55.9K 0.22% 137
2025
Q1
$263K Sell
318
-3,220
-91% -$2.68M 0.2% 134
2024
Q4
$2.73M Sell
3,538
-63
-2% -$52.2K 0.75% 20
2024
Q3
$3.19M Sell
3,601
-68
-2% -$61.1K 0.89% 20
2024
Q2
$3.32M Buy
3,669
+135
+4% +$108K 0.98% 18
2024
Q1
$2.75M Buy
3,534
+112
+3% +$79.7K 0.84% 20
2023
Q4
$1.99M Sell
3,422
-526
-13% -$307K 0.63% 29
2023
Q3
$2.12M Sell
3,948
-736
-16% -$379K 0.64% 26
2023
Q2
$2.2M Sell
4,684
-141
-3% -$59.1K 0.64% 31
2023
Q1
$1.66M Buy
4,825
+122
+3% +$41.1K 0.49% 33
2022
Q4
$1.72M Buy
4,703
+84
+2% +$29.8K 0.59% 34
2022
Q3
$1.49M Buy
+4,619
New +$1.46M 0.56% 33
2021
Q3
Sell
-904
Closed -$207K 137
2021
Q2
$207K Buy
+904
New +$182K 0.04% 127
2019
Q2
Sell
-1,779
Closed -$231K 139
2019
Q1
$231K Buy
+1,779
New +$216K 0.02% 106
2016
Q3
Sell
-63,101
Closed -$4.97M 80
2016
Q2
$4.97M Buy
+63,101
New +$4.75M 0.43% 43
2016
Q1
Sell
-46,139
Closed -$3.89M 97
2015
Q4
$3.89M Buy
+46,139
New +$3.83M 0.37% 47

Other funds holding LLY

Hanlon Investment Management's LLY Position: Q1 2026 in Review

Hanlon Investment Management reduced its Eli Lilly (LLY) stake by 2.5% in Q1 2026, selling an estimated $15.2K and leaving 576 shares worth $530K. The position accounts for 0.29% of the portfolio, ranked #119.

Hanlon Investment Management first reported a position in LLY in Q4 2015 and has held it in 19 quarters since. The position peaked at $4.97M in Q2 2016. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Hanlon Investment Management held 576 shares of Eli Lilly worth $530K as of Q1 2026.
  • Hanlon Investment Management sold 15 Eli Lilly shares in Q1 2026, an estimated $15.2K.
  • Eli Lilly made up 0.29% of Hanlon Investment Management's portfolio in Q1 2026, its #119 holding.
  • Hanlon Investment Management first reported a position in Eli Lilly in Q4 2015 and has held it in 19 quarters since.
  • Hanlon Investment Management's Eli Lilly position peaked at $4.97M in Q2 2016.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hanlon Investment Management's 13F filing for Q1 2026, filed 12 May 2026.